Effect of Clonidine, Yohimbine and Nalterexone on polycystic ovary syndrome patients
Not Applicable
- Conditions
- Polycystic ovary syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndrome
- Registration Number
- IRCT201204027883N4
- Lead Sponsor
- Vice- chanellor for research, Tehran University Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 88
Inclusion Criteria
female, age20-40 and they are suffering of Polycystic ovary syndrome
exclusion criteria:Body Mass Index:28, without basis disease and must not use drug.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estradiol,LH/FSH and Insuline. Timepoint: before intervention and after two mounts of it. Method of measurement: Utilization of diagnosis kite of Elisa.
- Secondary Outcome Measures
Name Time Method Adrenaline, Noradrenaline,Beta endorphine and Cortisol. Timepoint: Before intervention and two mounts of it. Method of measurement: Utilization of diagnosis Elisa kite.